Avid Bioservices, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Avid Bioservices, Inc.
Securing a place on the European Medicines Agency’s priority medicines scheme is not easy, but some companies have managed to make the grade more than once.
The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.
MSD and Astellas have joined Lilly, Takeda and AstraZeneca in making major investments in Ireland this year.
Some of China's makers of COVID-19 antivirals are fast-tracking neutralizing antibodies and peptide fusion inhibitors in clinical trials, while vaccine developers are embroiled in a tougher situation against the mutating coronavirus.
- Contract Manufacturing Organization
- Other Names / Subsidiaries
- Techniclone Corporation Peregrine Pharmaceuticals, Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.